Cancer Treatment Research in New Jersey
Cancer Treatment Research (93.395) awarded $38.1 million to recipients in New Jersey in 46 grants from fiscal 2021 to 2025, 0.7% of the program's national total. Rutgers the State University of New Jersey received the most, $18.3 million.
- Awarded in New Jersey$38.1 million
- Awards46
- Share of the program0.7%
- Rank among states24th of 50
- National total$5.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 20 | $10.2 million |
| FY 2022 | 27 | $11.0 million |
| FY 2023 | 18 | $5.3 million |
| FY 2024 | 14 | $6.2 million |
| FY 2025 | 11 | $5.4 million |
Recipients in New Jersey
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Rutgers the State University of New Jersey | Colleges and universities | 19 | $18.3 million |
| Rutgers, the State University of New Jersey | Colleges and universities | 3 | $2.9 million |
| HMH Hospitals Corporation | Nonprofits | 4 | $2.8 million |
| Coriell Institute for Medical Research, Inc. | Nonprofits | 1 | $2.2 million |
| Simphotek, Inc. | Small businesses | 1 | $2.0 million |
| Cellectar Biosciences, Inc | Small businesses | 1 | $1.7 million |
| Coridea, LLC | Small businesses | 1 | $1.6 million |
| Linnaeus Therapeutics Inc | Small businesses | 1 | $999,960 |
| The Trustees of Princeton University | Colleges and universities | 1 | $741,150 |
| Sentrimed Inc | Small businesses | 1 | $604,066 |
Open opportunities under this program
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
- Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
- NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
- Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)
See all 45 on the program page
Questions people ask
How much Cancer Treatment Research money goes to New Jersey?
$38.1 million from fiscal 2021 to 2025, across 46 awards. New Jersey ranks 24th of 50 states and territories for this program.
Who receives Cancer Treatment Research money in New Jersey?
The largest recipient is Rutgers the State University of New Jersey, with $18.3 million in 19 awards. Next are Rutgers, the State University of New Jersey and HMH Hospitals Corporation.
Can organizations in New Jersey apply now?
Yes, 45 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Treatment Research in other states
Other large programs in New Jersey
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- Federal Transit Formula Grants
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- National School Lunch Program
- Children's Health Insurance Program
- Special Education Grants to States
- 1332 State Innovation Waivers
- Title I Grants to Local Educational Agencies